Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease
Abstract
Response to immunosuppression is highly variable in systemic sclerosis (SSc)–related interstitial lung disease (ILD). This study was undertaken to determine whether a composite serum interferon (IFN)–inducible protein score exhibits predictive significance for the response to immunosuppression in SSc‐ILD.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 20, 2021
- Source ID
- 10.1002/art.41627
Entities
People
- Ami A Shah
- Daniel E. Furst
- Dennis Rünger
- Dinesh Khanna
- Donald P. Tashkin
- Elana J Bernstein
- Elizabeth R Volkmann
- Faye N. Hant
- Flavia V Castelino
- Jessica K Gordon
- Jonathan Goldin
- Jun Ying
- Maureen D Mayes
- Michael D. Roth
- Monique Hinchcliff
- Ning Li
- Philip J. Clements
- Robert M. Elashoff
- Robyn Domsic
- Shervin Assassi
- Tracy M Frech
- Victoria K Shanmugam
- Virginia D. Steen
Organizations
- Center for Scientific Review
- Columbia University
- Congressionally Directed Medical Research Programs
- George Washington University
- Georgetown University
- Harvard University
- Hospital for Special Surgery
- Johns Hopkins University
- Medical University of South Carolina
- Scleroderma Foundation
- University of California, Los Angeles
- University of Michigan
- University of Pittsburgh
- University of Texas Health Science Center at Houston
- University of Utah
- Yale University